Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool

ConditionLung Nodule
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorUniversity Hospitals Cleveland Medical Center

About this trial

chest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read. If the image is sent to the AI tool, the AI software will generate a report on if it detects a lung nodule or not. The image will then be sent to a radiologist to determine if there is agreement or disagreement with the AI tool.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Chest X-ray images of patients aged 18 - 89 years.

Modality: CR/DR/DX.

PA/view

Lung nodules measuring 6 mm -30 mm (for chest X-ray images where presence of nodules is required).

Disqualifiers

Incomplete view of the chest.

Lateral view

Known lung cancer at the time of Chest x-ray images.

Trial population

Chest x-rays collected on patients aged 18-89

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • AI Based CAD Software (qXR-Ln)

    Device

    All x-ray images have already been obtained and will then be run through CAD software for secondary nodule detection

Treatment groups

45,991 Participants
are divided into 2 treatment groups
Group A: Image going through AI tool1 intervention
Group B: image not going through AI tool0 interventions

Trial outcomes

Primary outcomes

1

number of patients with actionable lung nodule as measured by CT scan

Time frame
up to one year
2

total number of patients having chest x-ray

Time frame
up to one year
3

number of patients with high risk lung nodule as measured by CT scan

Time frame
up to one year
4

total number of patients referred for a CT scan

Time frame
up to one year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.